P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
University of Nebraska
Takeda
Novartis
Travera Inc
Marengo Therapeutics, Inc.
National Cancer Centre, Singapore